FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

Nature Genetics
S XiaoJ A Fletcher

Abstract

Various histological subtypes of leukaemia and lymphoma are associated with diagnostic chromosome translocations, and substantial strides have been made in determining the specific oncogenes targetted by those translocations. We report the cloning of a novel fusion oncogene associated with a unique leukaemia/lymphoma syndrome. Patients afflicted with this syndrome present with lymphoblastic lymphoma and a myeloproliferative disorder, often accompanied by pronounced peripheral eosinophilia and/or prominent eosinophilic infiltrates in the affected bone marrow, which generally progress to full-blown acute myelogenous leukaemia within a year of diagnosis. A specific chromosome translocation, t(8;13)(p11;q11-12), is found in both lymphoma and myeloid leukaemia cells from these patients, supporting bi-lineage differentiation from a transformed stem cell. We find that the 8p11 translocation breakpoints, in each of four patients, interrupt intron 8 of the fibroblast growth factor receptor 1 gene (FGFR1). These translocations are associated with aberrant transcripts in which four predicted zinc-finger domains, contributed by a novel and widely expressed chromosome-13 gene (ZNF198), are fused to the FGFR1 tyrosine-kinase domain. Transien...Continue Reading

References

Mar 11, 1992·The American Journal of Surgical Pathology·L V AbruzzoL J Medeiros
Feb 14, 1991·The New England Journal of Medicine·J A FletcherJ M Corson
Jan 1, 1989·Annual Review of Biochemistry·W H Burgess, T Maciag
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·W S PearD Baltimore
Nov 10, 1994·Nature·T H Rabbitts
Sep 11, 1993·Nucleic Acids Research·S ParimooS M Weissman
Jan 1, 1993·Cancer Genetics and Cytogenetics·K FaganP Harrison
Jul 1, 1996·Human Molecular Genetics·S M van der MaarelH H Ropers
Feb 15, 1997·Genomics·A S VerdierF Coulier
Apr 4, 1997·The Journal of Biological Chemistry·Q TongS M Jhiang

❮ Previous
Next ❯

Citations

Jul 4, 2001·Genes, Chromosomes & Cancer·G LiM R Emmert-Buck
Sep 11, 2001·Genes, Chromosomes & Cancer·J SohalN C Cross
Aug 1, 2013·Apoptosis : an International Journal on Programmed Cell Death·Kai Hung TiongChee-Onn Leong
Aug 23, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Andrew J RamsayVíctor Quesada
Mar 2, 2010·International Journal of Hematology·Martha Wadleigh, Ayalew Tefferi
May 18, 2012·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Bingxue ShangQuansheng Zhou
Dec 4, 2003·Biochemical and Biophysical Research Communications·Dennis R WarnerM Michele Pisano
Jul 9, 2013·Cytokine & Growth Factor Reviews·Guang LiangXiaokun Li
Oct 16, 2002·Cancer Genetics and Cytogenetics·Joris AndrieuxJean Luc Laï
Jul 31, 2001·Molecular and Cellular Endocrinology·J T WarrenL I Gilbert
Feb 20, 2002·Matrix Biology : Journal of the International Society for Matrix Biology·Haquima El MourabitMonique Aumailley
Jan 23, 2010·Nature Reviews. Cancer·Nicholas Turner, Richard Grose
Oct 18, 2013·Nature Reviews. Cancer·Alice T ShawJeffrey A Engelman
Aug 19, 2005·Leukemia·B DelavalD Birnbaum
Dec 13, 2005·Leukemia·K De Keersmaecker, J Cools
Oct 16, 2007·Oncogene·R A Van Etten
May 25, 2002·British Journal of Haematology·Rajeev GuptaBarbara J Bain
Oct 8, 1999·The New England Journal of Medicine·B J Bain
Dec 8, 2006·The New England Journal of Medicine·Peter J Campbell, Anthony R Green
Jun 22, 2006·Journal of the National Cancer Institute·Paul W Finch, Jeffrey S Rubin
May 16, 2000·La Revue du praticien·L Prin
Jan 15, 2010·Current Opinion in Hematology·Jason Gotlib
Oct 16, 2009·Journal of Pediatric Hematology/oncology·Wenyong W ZhangDolores López-Terrada
Jun 22, 2010·Journal of Pediatric Hematology/oncology·Xiangli ChenLinxiang Liu
Dec 29, 2007·The American Journal of Surgical Pathology·Francisco VegaLynne V Abruzzo
Nov 23, 2007·The Cancer Journal·Animesh Pardanani, Srdan Verstovsek
Jun 17, 2004·The Journal of Clinical Investigation·Jing ChenD Gary Gilliland

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.